Ornithine decarboxylase (ODC) is synthesized early after treatment with TPA, but not after treatment with other hyperplastic/non-promoting agents. ODC is also elevated in certain tumors. Elevated ODC levels lead to elevated polyamines. Transglutaminase (TG) links polyamines to various proteins, which may mediate the differentiation of epidermal cells. In this R01, which in many ways appears to be a continuation of an R29 (1990-95), the principal investigator wishes to investigate whether ODC expression and polyamines can cooperate with ras to cause epidermal tumors and/or affect differentiation of keratinocytes. (1) A retroviral vector containing the ODC gene was introduced into several cell types, which were assessed for the ability to cause tumors following sc injection. BK-1 cells, which contain no activated c-ras, gave no tumors, while SP-1 and 308 cells, which contain activated c-ras, gave tumors. All three showed elevated ODC and polyamines. This suggests that elevated ODC expression alone can be promoting at least partially. (2) ODC overexpression affected DNA synthesis, growth, differentiation, and TG levels (written generally--cell type unclear?). (3) Transgenic mice were generated with ODC gene expression driven from a keratin [K6 ]promoter. They have low birth weight and experience hair loss at 2 months. An abnormal dermis develops with large keratin-filled, benign, follicular cysts underneath a normal epidermis. Older mice develop benign keratocarcinomas. Hair loss can be prevented by administering the ODC specific inhibitor, DFMO, continuously from birth. There are 3 Specific Aims: (1) Can ODC overexpression cooperate with v-ras to enhance the tumor forming potential of BK-1 cells? (2) The ODC transgenic mice will be cross-bred with transgenic mice carrying activated v-ras (TG.AC). Will mice containing both transgenes develop epidermal tumors? (3) How inappropriate ODC activity affect differentiation of normal and initiated keratinocytes will be assessed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA070739-03S1
Application #
6209299
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Okano, Paul
Project Start
1996-08-01
Project End
2000-07-31
Budget Start
1998-08-01
Budget End
2000-07-31
Support Year
3
Fiscal Year
2000
Total Cost
$15,000
Indirect Cost
Name
Lankenau Institute for Medical Research
Department
Type
DUNS #
125797084
City
Wynnewood
State
PA
Country
United States
Zip Code
19096
Alexander, Eric T; Minton, Allyson; Peters, Molly C et al. (2017) A novel polyamine blockade therapy activates an anti-tumor immune response. Oncotarget 8:84140-84152
Hayes, Candace S; Shicora, Allyson C; Keough, Martin P et al. (2014) Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment. Cancer Immunol Res 2:274-85
Hayes, Candace S; DeFeo-Mattox, Karen; Woster, Patrick M et al. (2014) Elevated ornithine decarboxylase activity promotes skin tumorigenesis by stimulating the recruitment of bulge stem cells but not via toxic polyamine catabolic metabolites. Amino Acids 46:543-52
Gerhart, Jacquelyn; Hayes, Candace; Scheinfeld, Victoria et al. (2012) Myo/Nog cells in normal, wounded and tumor-bearing skin. Exp Dermatol 21:466-8
Keough, Martin P; Hayes, Candace S; DeFeo, Karen et al. (2011) Elevated epidermal ornithine decarboxylase activity suppresses contact hypersensitivity. J Invest Dermatol 131:158-66
Hayes, Candace S; Defeo, Karen; Dang, Hong et al. (2011) A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor development. Carcinogenesis 32:1340-8
Muller, Alexander J; DuHadaway, James B; Chang, Mee Young et al. (2010) Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion. Cancer Immunol Immunother 59:1655-63
Hogarty, Michael D; Norris, Murray D; Davis, Kimberly et al. (2008) ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma. Cancer Res 68:9735-45
Wei, Gang; DeFeo, Karen; Hayes, Candace S et al. (2008) Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes. Cancer Res 68:2214-22
Gilmour, Susan K (2007) Polyamines and nonmelanoma skin cancer. Toxicol Appl Pharmacol 224:249-56

Showing the most recent 10 out of 23 publications